Zwangslizenzen und staatliche Benutzungsanordnungen für Patente
GDPR and life sciences – part 2
von Thanos Rammos, LL.M. und Sally Annereau
The Bolar and related exemptions in Europe
What activity do they cover?
von mehreren Autoren
Falsified Medicine Directive continued: Safety features on medicinal products and its consequences
GDPR and private sector life sciences
von Debbie Heywood und Sally Annereau
Biosimilars – The economics of biosimilars: Market access, pricing and legal considerations
SPC manufacturing waiver (Part 2): The fairy tale of day-1 entry under the manufacturing and stockpiling waiver – a German view
von Verena Bertram und Dr. Anja Lunze, LL.M.
Taking a new approach to European patent law
von Dr Paul England
Patenting of gene and protein sequences: an EU and US perspective
First Dutch GDPR fine for failing to ensure security of patient files
Dr Bill Frankland: Penicillin, the pollen count and perspectives on medicine